Zacks.com Spotlights StoneCo, General Motors, Enersys, Deutsche, and Keros
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2025
0mins
Source: NASDAQ.COM
Value Stocks Overview: The article discusses various stocks including StoneCo, General Motors, Enersys, Deutsche Bank, and Keros Therapeutics, highlighting the importance of the price-to-book (P/B) ratio as a valuation tool for identifying undervalued stocks with growth potential.
Understanding Book Value: Book value is defined as the total value remaining for shareholders if a company were to liquidate, calculated by subtracting total liabilities from total assets, and is crucial for assessing whether a stock is under- or overpriced.
P/B Ratio Insights: A P/B ratio of less than one indicates a potentially undervalued stock, while a ratio above one suggests overvaluation; however, investors should be cautious as a low P/B can also signal poor asset returns or overstated assets.
Investment Recommendations: The article provides insights into the projected earnings growth rates for the mentioned companies, encouraging readers to consider these stocks for investment while also recommending the use of additional financial ratios for informed decision-making.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy STNE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on STNE
Wall Street analysts forecast STNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STNE is 22.00 USD with a low forecast of 20.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.190
Low
20.00
Averages
22.00
High
25.00
Current: 16.190
Low
20.00
Averages
22.00
High
25.00
About STNE
StoneCo Ltd. is a provider of financial technology and software solutions. The Company designed its cloud-based technology platform, namely the Stone Business Model, for its clients to connect, get paid, and grow their businesses. Its segments include financial services and software. In financial services, it offers payments, digital banking, and credit solutions, focused mainly on Micro, Small, and Medium Businesses (MSMBs). In software, it offers Point of Sale (POS) and Enterprise Resource Planning (ERP) solutions for different retail and service verticals, Customer Relationship Management (CRM), engagement tools, electronic commerce, and order management system solutions. It also provides digital product enhancements to help its merchants improve their consumers' experience, such as its split-payment processing, multi-payment processing, recurring payments for subscriptions, and one-click buy functionality. It provides its clients with store, life, and health insurance solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
US Stock Market Volatile, Nasdaq Hits 3.5-Week High
- Mixed Market Performance: On Wednesday, the S&P 500 Index fell by 0.34% and the Dow Jones Industrial Average dropped by 0.94%, while the Nasdaq 100 rose by 0.06%, indicating a divergence in market performance, particularly influenced by weakness in chipmakers and data storage stocks.
- Weak Employment Data: The December ADP employment report revealed only 41,000 jobs added in the private sector, falling short of the expected 50,000, reflecting a weaker US labor market that may lead to a dovish shift in Fed policy.
- Eased Inflation Concerns: Eurozone's December core CPI rose by 2.3% year-on-year, below the expected 2.4%, which alleviated inflation worries and contributed to lower European bond yields, further impacting global market sentiment.
- Focus on Upcoming Economic Data: The market is set to closely monitor upcoming economic reports, including an expected 5% increase in Q3 nonfarm productivity and a projected rise of 70,000 in nonfarm payrolls, indicating potential economic growth momentum and influencing market expectations for Fed policy.
See More
S&P 500 Hits All-Time High Amid Mixed Economic Signals
- S&P 500 New High: The S&P 500 index rose by 0.10% today, reaching an all-time high, reflecting market confidence in economic recovery, despite the Dow Jones falling by 0.36% due to mixed economic data.
- Weak Employment Data: The December ADP employment report indicated only 41,000 jobs were added in the private sector, falling short of the expected 50,000, highlighting weakness in the U.S. labor market that may influence Federal Reserve policy.
- Strong Services Sector: The December ISM services index unexpectedly rose by 1.8 to 54.4, surpassing expectations, indicating the fastest expansion in the services sector in 14 months, which could support economic growth.
- European Inflation Eases: Eurozone's December core CPI increased by 2.3% year-on-year, below the expected 2.4%, alleviating inflation concerns and leading to a decline in European bond yields.
See More
S&P 500 Hits All-Time High as Stock Indexes Mostly Rise
- S&P 500 New High: The S&P 500 Index rose by 0.13%, reaching an all-time high, indicating strong market confidence in economic recovery, which may attract more investor interest.
- Employment Data Impact: The US December ADP employment report showed an increase of 41,000 jobs, below the expected 50,000, leading to a decline in Treasury yields that could influence the Fed's monetary policy direction.
- European Inflation Easing: Eurozone December core CPI rose 2.3% year-on-year, below the expected 2.4%, alleviating inflation concerns and pushing European bond yields lower.
- Mortgage Application Changes: US mortgage applications rose by 0.3%, with purchase mortgage applications down 6.2% and refinancing applications up 7.4%, reflecting market sensitivity to interest rate changes.
See More
STNE Stock Shows Significant Volatility with 52-Week High of $19.95
- Stock Price Analysis: STNE's 52-week low is $7.7223 per share, while the high is $19.95, with the last trade at $15.16, indicating significant volatility in its stock price, reflecting varying market expectations regarding its future performance.
- Market Trend Observation: The current stock price is approximately 76% of the 52-week high, suggesting a recovery in investor confidence in STNE, which may attract more attention from investors regarding its growth potential.
- Technical Indicator Analysis: STNE's stock price has crossed above the 200-day moving average, potentially signaling a bullish trend in the short term, as such technical signals are often viewed as positive buy indicators that could further drive the stock price upward.
- Investor Sentiment Shift: As the stock price approaches its high, market sentiment may become more optimistic, prompting investors to reassess their strategies, which could influence STNE's market performance and liquidity.
See More
Robinhood and Coinbase See Significant Trading Volume on Friday
- Volume Analysis: On Friday, Robinhood Markets traded over 7.5 million shares, with a price decline of about 0.3%, indicating ongoing market interest but failing to drive price appreciation.
- Coinbase Dynamics: Coinbase Global saw over 3.9 million shares traded on Friday, with a price drop of approximately 0.9%, reflecting investor uncertainty in the cryptocurrency market.
- Stonex Outperformance: Stonex Group rose about 1.3% during Friday's trading, making it the best-performing component in the ETF, showcasing its relative strength in the market.
- Miami International Holdings Lagging: Miami International Holdings fell by approximately 1.2%, underperforming within the iShares U.S. Broker-Dealers & Securities Exchanges ETF, possibly indicating market concerns about its future growth prospects.
See More
Novo Nordisk Receives FDA Approval for Wegovy, Shares Surge 8.6%
- FDA Approval: Novo Nordisk's GLP-1 drug Wegovy received FDA approval, marking the first of its kind globally, which signifies a major breakthrough for the company in the weight loss medication market and is expected to drive sales growth and enhance competitive positioning.
- Stock Surge: Following the approval news, Novo Nordisk's shares rose 8.6% to $52.26, reflecting strong investor confidence in the potential market demand for the new drug, which may enhance the company's market capitalization and investment appeal.
- Market Reaction: Other related companies like WW International and Lifezone Metals also saw gains due to positive market sentiment, with WW International's stock jumping 14.4%, indicating increased investor interest in health and weight loss-related products, potentially boosting overall industry growth.
- Industry Impact: Novo Nordisk's successful approval may prompt other pharmaceutical companies to accelerate the development of similar products, thereby driving competition in the GLP-1 market and fostering innovation and market expansion.
See More
US Stock Market Volatile, Nasdaq Hits 3.5-Week High
- Mixed Market Performance: On Wednesday, the S&P 500 Index fell by 0.34% and the Dow Jones Industrial Average dropped by 0.94%, while the Nasdaq 100 rose by 0.06%, indicating a divergence in market performance, particularly influenced by weakness in chipmakers and data storage stocks.
- Weak Employment Data: The December ADP employment report revealed only 41,000 jobs added in the private sector, falling short of the expected 50,000, reflecting a weaker US labor market that may lead to a dovish shift in Fed policy.
- Eased Inflation Concerns: Eurozone's December core CPI rose by 2.3% year-on-year, below the expected 2.4%, which alleviated inflation worries and contributed to lower European bond yields, further impacting global market sentiment.
- Focus on Upcoming Economic Data: The market is set to closely monitor upcoming economic reports, including an expected 5% increase in Q3 nonfarm productivity and a projected rise of 70,000 in nonfarm payrolls, indicating potential economic growth momentum and influencing market expectations for Fed policy.
See More
S&P 500 Hits All-Time High Amid Mixed Economic Signals
- S&P 500 New High: The S&P 500 index rose by 0.10% today, reaching an all-time high, reflecting market confidence in economic recovery, despite the Dow Jones falling by 0.36% due to mixed economic data.
- Weak Employment Data: The December ADP employment report indicated only 41,000 jobs were added in the private sector, falling short of the expected 50,000, highlighting weakness in the U.S. labor market that may influence Federal Reserve policy.
- Strong Services Sector: The December ISM services index unexpectedly rose by 1.8 to 54.4, surpassing expectations, indicating the fastest expansion in the services sector in 14 months, which could support economic growth.
- European Inflation Eases: Eurozone's December core CPI increased by 2.3% year-on-year, below the expected 2.4%, alleviating inflation concerns and leading to a decline in European bond yields.
See More
S&P 500 Hits All-Time High as Stock Indexes Mostly Rise
- S&P 500 New High: The S&P 500 Index rose by 0.13%, reaching an all-time high, indicating strong market confidence in economic recovery, which may attract more investor interest.
- Employment Data Impact: The US December ADP employment report showed an increase of 41,000 jobs, below the expected 50,000, leading to a decline in Treasury yields that could influence the Fed's monetary policy direction.
- European Inflation Easing: Eurozone December core CPI rose 2.3% year-on-year, below the expected 2.4%, alleviating inflation concerns and pushing European bond yields lower.
- Mortgage Application Changes: US mortgage applications rose by 0.3%, with purchase mortgage applications down 6.2% and refinancing applications up 7.4%, reflecting market sensitivity to interest rate changes.
See More
STNE Stock Shows Significant Volatility with 52-Week High of $19.95
- Stock Price Analysis: STNE's 52-week low is $7.7223 per share, while the high is $19.95, with the last trade at $15.16, indicating significant volatility in its stock price, reflecting varying market expectations regarding its future performance.
- Market Trend Observation: The current stock price is approximately 76% of the 52-week high, suggesting a recovery in investor confidence in STNE, which may attract more attention from investors regarding its growth potential.
- Technical Indicator Analysis: STNE's stock price has crossed above the 200-day moving average, potentially signaling a bullish trend in the short term, as such technical signals are often viewed as positive buy indicators that could further drive the stock price upward.
- Investor Sentiment Shift: As the stock price approaches its high, market sentiment may become more optimistic, prompting investors to reassess their strategies, which could influence STNE's market performance and liquidity.
See More
Robinhood and Coinbase See Significant Trading Volume on Friday
- Volume Analysis: On Friday, Robinhood Markets traded over 7.5 million shares, with a price decline of about 0.3%, indicating ongoing market interest but failing to drive price appreciation.
- Coinbase Dynamics: Coinbase Global saw over 3.9 million shares traded on Friday, with a price drop of approximately 0.9%, reflecting investor uncertainty in the cryptocurrency market.
- Stonex Outperformance: Stonex Group rose about 1.3% during Friday's trading, making it the best-performing component in the ETF, showcasing its relative strength in the market.
- Miami International Holdings Lagging: Miami International Holdings fell by approximately 1.2%, underperforming within the iShares U.S. Broker-Dealers & Securities Exchanges ETF, possibly indicating market concerns about its future growth prospects.
See More
Novo Nordisk Receives FDA Approval for Wegovy, Shares Surge 8.6%
- FDA Approval: Novo Nordisk's GLP-1 drug Wegovy received FDA approval, marking the first of its kind globally, which signifies a major breakthrough for the company in the weight loss medication market and is expected to drive sales growth and enhance competitive positioning.
- Stock Surge: Following the approval news, Novo Nordisk's shares rose 8.6% to $52.26, reflecting strong investor confidence in the potential market demand for the new drug, which may enhance the company's market capitalization and investment appeal.
- Market Reaction: Other related companies like WW International and Lifezone Metals also saw gains due to positive market sentiment, with WW International's stock jumping 14.4%, indicating increased investor interest in health and weight loss-related products, potentially boosting overall industry growth.
- Industry Impact: Novo Nordisk's successful approval may prompt other pharmaceutical companies to accelerate the development of similar products, thereby driving competition in the GLP-1 market and fostering innovation and market expansion.
See More
